RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report

RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report

We present the case of a 49-year-old male with metastatic epidermal growth factor receptor (EGFR) mutation-positive adenocarcinoma of the lung that continues to outlive stage IV diagnosis of non-small cell lung cancer after treatment with RRx-001, an experimental anticancer agent with epigenetic and...

Full description

Bibliographic Details
Main Authors: Christina Brzezniak, Bruno A. Schmitz, Paul G. Peterson, Aiste Degesys, Bryan T. Oronsky, Jan J. Scicinski, Scott Z. Caroen, Corey A. Carter
Format: Article
Language:English
Published: Karger Publishers 2016-01-01
Series:Case Reports in Oncology
Subjects:
RRx-001
Non-small cell lung cancer
Epidermal growth factor receptor
Online Access:http://www.karger.com/Article/FullText/443605

Internet

http://www.karger.com/Article/FullText/443605

Similar Items